#BEGIN_DRUGCARD DB02120

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
38231-86-6

# ChEBI_ID:
Not Available

# Chemical_Formula:
C7H13NO4

# Chemical_IUPAC_Name:
(1R,2S,3R,6S)-6-amino-4-(hydroxymethyl)cyclohex-4-ene-1,2,3-triol

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
6-Amino-4-Hydroxymethyl-Cyclohex-4-Ene-1,2,3-Triol

# HET_ID:
ACI

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C7H13NO4/c8-4-1-3(2-9)5(10)7(12)6(4)11/h1,4-7,9-12H,2,8H2/t4-,5+,6+,7-/m0/s1

# InChI_Key:
InChIKey=XPHOBMULWMGEBA-WNJXEPBRSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
2120

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
175.1824

# Molecular_Weight_Mono:
175.084457909

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1V3L

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-2.3

# Predicted_LogS:
0.29

# Predicted_Water_Solubility:
3.42e+02 g/l

# Primary_Accession_No:
DB02120

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
10749764

# PubChem_Substance_ID:
46504853

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00413

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@@H]1O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:49 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasmic

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
M17366

# Drug_Target_1_GenBank_ID_Protein:
142676

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
cgt

# Drug_Target_1_Gene_Sequence:
>2142 bp
ATGAAAAGATTTATGAAACTAACAGCCGTATGGACACTCTGGTTATCCCTCACGCTGGGC
CTCTTGAGCCCGGTCCACGCAGCCCCGGATACCTCGGTATCCAACAAGCAGAATTTCAGC
ACGGATGTCATATATCAGATCTTCACCGACCGGTTCTCGGACGGCAATCCGGCCAACAAT
CCGACCGGCGCGGCATTTGACGGATCATGTACGAATCTTCGCTTATACTGCGGCGGCGAC
TGGCAAGGCATCATCAACAAAATCAACGACGGTTATTTGACCGGCATGGGCATTACGGCC
ATCTGGATTTCACAGCCTGTCGAGAATATCTACAGCGTGATCAACTACTCCGGCGTCAAT
AATACGGCTTATCACGGCTACTGGGCCCGGGACTTCAAGAAGACCAATCCGGCCTACGGG
ACGATGCAGGACTTCAAAAACCTGATCGACACCGCGCATGCGCATAACATAAAAGTCATC
ATCGACTTTGCACCGAACCATACATCTCCGGCTTCTTCGGATGATCCTTCTTTTGCAGAG
AACGGCCGCTTGTACGATAACGGCAACCTGCTCGGCGGATACACCAACGATACCCAAAAT
CTGTTCCACCATTATGGCGGCACGGATTTCTCCACCATTGAGAACGGCATTTATAAAAAC
CTGTACGATCTGGCTGACCTGAATCATAACAACAGCAGCGTCGATGTGTATCTGAAGGAT
GCCATCAAAATGTGGCTCGACCTCGGGGTGGACGGCATTCGCGTGGACGCGGTCAAGCAT
ATGCCATTCGGCTGGCAGAAGAGCTTTATGGCCACCATTAACAACTACAAGCCGGTCTTC
ACCTTCGGCGAATGGTTCCTAGGCGTCAATGAGATCAGTCCGGAATACCATCAATTCGCT
AACGAGTCCGGGATGAGCCTGCTCGATTTCCGCTTTGCCCAGAAGGCTCGGCAAGTGTTC
AGGGACAACACCGACAATATGTACGGCCTGAAGGCGATGCTGGAGGGCTCTGAAGTAGAC
TATGCCCAGGTGAATGACCAGGTGACCTTCATCGACAATCATGACATGGAGCGTTTCCAC
ACCAGCAATGGCGACAGACGGAAGCTGGAGCAGGCGCTGGCCTTTACCCTGACTTCACGC
GGTGTGCCTGCCATCTATTACGGCAGCGAGCAGTATATGTCTGGCGGGAATGATCCGGAC
AACCGTGCACGACTTCCTTCCTTCTCCACGACGACGACCGCATATCAAGTCATCCAAAAG
CTCGCTCCGCTCCGCAAATCCAACCCGGCCATCGCTTACGGTTCCACACATGAGCGCTGG
ATCAACAACGATGTGATCATCTATGAACGCAAATTCGGCAATAACGTGGCCGTTGTTGCC
ATTAACCGCAATATGAACACACCGGCTTCAATTACCGGCCTTGTCACTTCCCTCCGCAGG
GCCAGCTATAACGATGTGCTCGGCGGAATTCTGAACGGCAATACGCTAACCGTGGGTGCT
GGCGGTGCAGCTTCCAACTTTACCCTGGCTCCTGGCGGCACTGCTGTATGGCAGTACACA
ACCGATGCCACAACTCCGATCATCGGCAATGTCGGTCCGATGATGGCAAAGCCAGGGGTC
ACGATTACGATTGACGGCCGCGGCTTCGGCTCCGGCAAGGGAACGGTTTACTTCGGTACA
ACGGCAGTCACTGGCGCGGACATCGTAGCTTGGGAAGATACACAGATTCAGGTGAAAATC
CCTGCGGTCCCTGGCGGCATCTATGATATCAGAGTTGCCAACGCAGCCGGAGCAGCCAGC
AACATCTACGACAATTTCGAGGTGCTGACCGGAGACCAGGTCACCGTTCGGTTCGTAATC
AACAATGCCACGACGGCGCTGGGACAGAATGTGTTCCTCACGGGCAATGTCAGCGAGCTG
GGCAACTGGGATCCGAACAACGCGATCGGCCCGATGTATAATCAGGTCGTCTACCAATAC
CCGACTTGGTATTATGATGTGAGCGTTCCGGCAGGCCAAACGATTGAATTTAAATTCCTG
AAAAAGCAAGGCTCCACCGTCACATGGGAAGGCGGCGCGAATCGCACCTTCACCACCCCA
ACCAGCGGCACGGCAACGGTGAATGTGAACTGGCAGCCTTAA

# Drug_Target_1_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_1_General_References:
2957361	Kimura K, Kataoka S, Ishii Y, Takano T, Yamane K: Nucleotide sequence of the beta-cyclodextrin glucanotransferase gene of alkalophilic Bacillus sp. strain 1011 and similarity of its amino acid sequence to those of alpha-amylases. J Bacteriol. 1987 Sep;169(9):4399-402.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2508

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
78341

# Drug_Target_1_Name:
Cyclomaltodextrin glucanotransferase

# Drug_Target_1_Number_of_Residues:
713

# Drug_Target_1_PDB_ID:
1UKQ

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00128	Alpha-amylase
PF00686	CBM_20
PF01833	TIG
PF02806	Alpha-amylase_C

# Drug_Target_1_Protein_Sequence:
>Cyclomaltodextrin glucanotransferase precursor
MKRFMKLTAVWTLWLSLTLGLLSPVHAAPDTSVSNKQNFSTDVIYQIFTDRFSDGNPANN
PTGAAFDGSCTNLRLYCGGDWQGIINKINDGYLTGMGITAIWISQPVENIYSVINYSGVN
NTAYHGYWARDFKKTNPAYGTMQDFKNLIDTAHAHNIKVIIDFAPNHTSPASSDDPSFAE
NGRLYDNGNLLGGYTNDTQNLFHHYGGTDFSTIENGIYKNLYDLADLNHNNSSVDVYLKD
AIKMWLDLGVDGIRVDAVKHMPFGWQKSFMATINNYKPVFTFGEWFLGVNEISPEYHQFA
NESGMSLLDFRFAQKARQVFRDNTDNMYGLKAMLEGSEVDYAQVNDQVTFIDNHDMERFH
TSNGDRRKLEQALAFTLTSRGVPAIYYGSEQYMSGGNDPDNRARLPSFSTTTTAYQVIQK
LAPLRKSNPAIAYGSTHERWINNDVIIYERKFGNNVAVVAINRNMNTPASITGLVTSLRR
ASYNDVLGGILNGNTLTVGAGGAASNFTLAPGGTAVWQYTTDATTPIIGNVGPMMAKPGV
TITIDGRGFGSGKGTVYFGTTAVTGADIVAWEDTQIQVKIPAVPGGIYDIRVANAAGAAS
NIYDNFEVLTGDQVTVRFVINNATTALGQNVFLTGNVSELGNWDPNNAIGPMYNQVVYQY
PTWYYDVSVPAGQTIEFKFLKKQGSTVTWEGGANRTFTTPTSGTATVNVNWQP

# Drug_Target_1_Reaction:
Cyclizes part of a 1,4-alpha-D-glucan chain by formation of a 1,4-alpha-D-glucosidic bond

# Drug_Target_1_Signals:
1-27

# Drug_Target_1_Specific_Function:
Cyclizes part of a 1,4-alpha-D-glucan chain by formation of a 1,4-alpha-D-glucosidic bond

# Drug_Target_1_SwissProt_ID:
P05618

# Drug_Target_1_SwissProt_Name:
CDGT_BACS0

# Drug_Target_1_Synonyms:
CGTase
Cyclodextrin-glycosyltransferase
Cyclomaltodextrin glucanotransferase precursor
EC 2.4.1.19

# Drug_Target_1_Theoretical_pI:
5.76

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Cytoplasmic

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
X78145

# Drug_Target_2_GenBank_ID_Protein:
510492

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
cgt

# Drug_Target_2_Gene_Sequence:
>2142 bp
ATGAAGAAATTTCTGAAATCGACAGCTGCGCTTGCCCTGGGATTATCGCTGACGTTCGGG
CTTTTCAGCCCTGCCCAGGCCGCGCCGGATACCTCGGTATCCAACAAGCAAAATTTCAGC
ACCGACGTCATCTATCAAATTTTCACCGACAGGTTTTCGGACGGCAATCCCGCCAACAAT
CCGACCGGCGCGGCGTTTGACGGAACCTGCACGAACCTCCGGCTGTATTGCGGCGGCGAC
TGGCAGGGCATCATCAACAAAATCAACGACGGTTACCTGACCGGGATGGGCGTTACCGCC
ATCTGGATCTCCCAGCCGGTCGAAAACATCTACAGCATCATCAATTATTCCGGCGTAAAC
AACACGGCCTATCACGGCTACTGGGCCCGGGACTTCAAGAAGACGAATCCGGCCTACGGC
ACGATTGCGGACTTCCAGAACCTGATCGCCGCCGCGCATGCAAAAAACATCAAAGTCATT
ATCGACTTTGCCCCGAACCATACGTCGCCCGCCTCGTCCGACCAGCCTTCCTTTGCGGAA
AACGGCCGGCTGTACGATAACGGCACGCTGCTCGGGGGATACACGAACGATACGCAGAAC
CTGTTCCACCATAACGGCGGCACGGACTTTTCCACGACCGAAAACGGCATCTACAAAAAC
CTGTACGATCTCGCCGACCTGAACCATAACAACAGCACCGTGGACGTCTACTTGAAGGAC
GCGATCAAAATGTGGCTGGACCTCGGCATCGACGGCATCCGCATGGATGCGGTGAAGCAT
ATGCCGTTCGGCTGGCAGAAGAGCTTTATGGCTGCCGTCAACAACTATAAGCCGGTCTTT
ACCTTCGGCGAATGGTTCCTGGGCGTAAATGAAGTGAGCCCGGAAAACCATAAGTTTGCC
AACGAATCCGGCATGAGCCTGCTTGATTTCCGTTTTGCCCAAAAGGTGCGGCAGGTGTTC
CGGGACAACACCGACAATATGTACGGCCTGAAGGCGATGCTGGAGGGCTCCGCAGCCGAT
TACGCCCAGGTGGATGACCAGGTGACGTTCATCGACAACCATGACATGGAGCGTTTCCAC
GCAAGCAATGCAAACCGCCGGAAGCTGGAGCAAGCGCTTGCGTTCACGCTGACCTCGCGC
GGCGTCCCCGCCATTTATTACGGCACCGAGCAGTACATGTCGGGCGGGACCGATCCGGAC
AACCGGGCGCGGATCCCTTCCTTCTCCACGTCGACGACCGCCTATCAGGTCATTCAAAAG
CTGGCGCCGCTGCGCAAGTGCAACCCGGCCATCGCCTACGGATCGACGCAGGAGCGCTGG
ATCAACAACGACGTGCTCATTTATGAGCGCAAATTCGGCAGCAACGTTGCCGTCGTTGCC
GTCAACCGCAATTTAAACGCGCCGGCTTCCATTTCGGGACTTGTCACTTCCCTGCCGCAA
GGCAGCTACAACGACGTCCTTGGCGGCCTTCTGAACGGCAACACGTTATCGGTAGGCTCC
GGCGGGGCCGCCTCCAATTTCACGCTTGCGGCCGGCGGCACGGCGGTGTGGCAGTACACC
GCGGCTACGGCGACGCCGACCATCGGGCATGTCGGGCCGATGATGGCCAAGCCGGGCGTG
ACGATCACGATCGACGGCCGCGGCTTCGGCTCTAGCAAAGGCACCGTCTACTTCGGTACG
ACGGCGGTGAGCGGGGCGGACATCACGTCTTGGGAAGACACGCAGATCAAAGTGAAAATT
CCGGCCGTCGCAGGCGGCAACTACAACATTAAAGTCGCAAACGCTGCCGGAACGGCAAGC
AATGTGTATGACAACTTCGAGGTATTGTCCGGAGACCAGGTCAGCGTCCGCTTCGTGGTC
AACAACGCGACGACGGCCCTTGGGCAAAATGTGTACCTGACGGGCAGTGTCAGCGAGCTG
GGGAACTGGGACCCGGCAAAAGCAATCGGGCCGATGTACAATCAGGTCGTTTACCAATAT
CCGAACTGGTATTATGACGTCAGCGTTCCGGCCGGCAAAACGATCGAGTTCAAGTTTTTG
AAAAAACAAGGCTCCACCGTCACGTGGGAAGGCGGCAGCAACCACACCTTCACCGCGCCG
TCCAGCGGCACCGCGACCATTAACGTGAATTGGCAGCCATAA

# Drug_Target_2_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_2_General_References:
7493956	Knegtel RM, Strokopytov B, Penninga D, Faber OG, Rozeboom HJ, Kalk KH, Dijkhuizen L, Dijkstra BW: Crystallographic studies of the interaction of cyclodextrin glycosyltransferase from Bacillus circulans strain 251 with natural substrates and products. J Biol Chem. 1995 Dec 8;270(49):29256-64.
8107143	Lawson CL, van Montfort R, Strokopytov B, Rozeboom HJ, Kalk KH, de Vries GE, Penninga D, Dijkhuizen L, Dijkstra BW: Nucleotide sequence and X-ray structure of cyclodextrin glycosyltransferase from Bacillus circulans strain 251 in a maltose-dependent crystal form. J Mol Biol. 1994 Feb 18;236(2):590-600.
8672460	Strokopytov B, Knegtel RM, Penninga D, Rozeboom HJ, Kalk KH, Dijkhuizen L, Dijkstra BW: Structure of cyclodextrin glycosyltransferase complexed with a maltononaose inhibitor at 2.6 angstrom resolution. Implications for product specificity. Biochemistry. 1996 Apr 2;35(13):4241-9.
8955113	Penninga D, van der Veen BA, Knegtel RM, van Hijum SA, Rozeboom HJ, Kalk KH, Dijkstra BW, Dijkhuizen L: The raw starch binding domain of cyclodextrin glycosyltransferase from Bacillus circulans strain 251. J Biol Chem. 1996 Dec 20;271(51):32777-84.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
2523

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
77310

# Drug_Target_2_Name:
Cyclomaltodextrin glucanotransferase

# Drug_Target_2_Number_of_Residues:
713

# Drug_Target_2_PDB_ID:
2CXG

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00128	Alpha-amylase
PF00686	CBM_20
PF01833	TIG
PF02806	Alpha-amylase_C

# Drug_Target_2_Protein_Sequence:
>Cyclomaltodextrin glucanotransferase precursor
MKKFLKSTAALALGLSLTFGLFSPAQAAPDTSVSNKQNFSTDVIYQIFTDRFSDGNPANN
PTGAAFDGTCTNLRLYCGGDWQGIINKINDGYLTGMGVTAIWISQPVENIYSIINYSGVN
NTAYHGYWARDFKKTNPAYGTIADFQNLIAAAHAKNIKVIIDFAPNHTSPASSDQPSFAE
NGRLYDNGTLLGGYTNDTQNLFHHNGGTDFSTTENGIYKNLYDLADLNHNNSTVDVYLKD
AIKMWLDLGIDGIRMDAVKHMPFGWQKSFMAAVNNYKPVFTFGEWFLGVNEVSPENHKFA
NESGMSLLDFRFAQKVRQVFRDNTDNMYGLKAMLEGSAADYAQVDDQVTFIDNHDMERFH
ASNANRRKLEQALAFTLTSRGVPAIYYGTEQYMSGGTDPDNRARIPSFSTSTTAYQVIQK
LAPLRKCNPAIAYGSTQERWINNDVLIYERKFGSNVAVVAVNRNLNAPASISGLVTSLPQ
GSYNDVLGGLLNGNTLSVGSGGAASNFTLAAGGTAVWQYTAATATPTIGHVGPMMAKPGV
TITIDGRGFGSSKGTVYFGTTAVSGADITSWEDTQIKVKIPAVAGGNYNIKVANAAGTAS
NVYDNFEVLSGDQVSVRFVVNNATTALGQNVYLTGSVSELGNWDPAKAIGPMYNQVVYQY
PNWYYDVSVPAGKTIEFKFLKKQGSTVTWEGGSNHTFTAPSSGTATINVNWQP

# Drug_Target_2_Reaction:
Cyclizes part of a 1,4-alpha-D-glucan chain by formation of a 1,4-alpha-D-glucosidic bond

# Drug_Target_2_Signals:
1-27

# Drug_Target_2_Specific_Function:
Cyclizes part of a 1,4-alpha-D-glucan chain by formation of a 1,4-alpha-D-glucosidic bond

# Drug_Target_2_SwissProt_ID:
P43379

# Drug_Target_2_SwissProt_Name:
CDGT2_BACCI

# Drug_Target_2_Synonyms:
CGTase
Cyclodextrin-glycosyltransferase
Cyclomaltodextrin glucanotransferase precursor
EC 2.4.1.19

# Drug_Target_2_Theoretical_pI:
6.52

# Drug_Target_2_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Secreted protein

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
Not Available

# Drug_Target_3_GenBank_ID_Gene:
M18862

# Drug_Target_3_GenBank_ID_Protein:
142497

# Drug_Target_3_GeneCard_ID:
Not Available

# Drug_Target_3_Gene_Name:
Not Available

# Drug_Target_3_Gene_Sequence:
>1557 bp
ATGAAAATGAGAACAGGAAAAAAGGGTTTTTTAAGTATTTTATTAGCGTTCTTATTGGTG
ATTACTTCAATACCGTTTACTTTAGTAGATGTAGAAGCACATCATAACGGTACGAACGGG
ACAATGATGCAATACTTTGAATGGTATCTACCTAATGACGGAAATCATTGGAATCGATTA
AACTCTGATGCGAGTAACCTTAAAAGCAAAGGGATTACAGCGGTGTGGATTCCTCCAGCA
TGGAAGGGCGCTTCTCAAAATGACGTAGGATACGGAGCCTATGACCTGTATGATCTGGGA
GAATTTAATCAAAAAGGTACCGTCCGTACAAAATATGGAACACGTAGTCAGTTACAAGCT
GCGGTAACCTCCTTAAAAAATAATGGAATTCAAGTATATGGTGACGTTGTTATGAATCAC
AAAGGTGGCGCAGACGCTACTGAAATGGTAAGGGCCGTTGAAGTGAATCCCAATAACCGT
AACCAAGAAGTGACTGGTGAATATACCATTGAAGCTTGGACTAGATTTGATTTTCCAGGG
CGAGGAAATACTCATTCTAGCTTTAAATGGAGATGGTATCATTTTGATGGTGTGGATTGG
GATCAGTCACGTAGACTGAACAATCGCATCTATAAATTTAGAGGTCATGGCAAAGCTTGG
GATTGGGAAGTTGATACGGAAAATGGTAATTATGATTATTTAATGTACGCTGATATTGAT
ATGGATCACCCAGAAGTAGTAAATGAATTAAGAAATTGGGGTGTTTGGTACACAAACACA
TTAGGACTCGATGGATTTAGAATAGATGCGGTTAAACATATAAAGTATAGCTTTACGCGC
GATTGGATTAATCACGTTAGAAGTGCAACAGGTAAAAATATGTTTGCGGTTGCTGAGTTT
TGGAAGAATGATTTAGGTGCAATTGAAAACTATCTGCAGAAAACAAACTGGAACCATTCA
GTCTTTGATGTGCCGTTACATTATAATCTTTATAATGCATCAAAAAGCGGAGGGAACTAT
GATATGCGAAACATATTTAATGGAACGGTTGTTCAACGACATCCAAGTCATGCTGTAACA
TTTGTTGATAATCATGATTCGCAGCCTGAAGAAGCATTAGAATCTTTTGTTGAAGAATGG
TTTAAACCATTAGCGTATGCGCTTACATTAACGCGTGAACAAGGATACCCTTCTGTATTT
TACGGAGATTATTATGGGATTCCAACACATGGAGTGCCAGCAATGAGATCAAAAATCGAT
CCGATTTTAGAAGCACGTCAAAAGTATGCATACGGAAAACAAAATGATTACTTAGACCAT
CATAATATCATTGGTTGGACGCGTGAAGGGAATACAGCACACCCCAATTCAGGTCTAGCT
ACCATCATGTCTGATGGAGCGGGTGGAAGTAAGTGGATGTTTGTTGGGCGTAATAAGGCT
GGTCAAGTATGGAGTGATATTACAGGAAACCGTACAGGTACGGTTACAATCAATGCAGAC
GGTTGGGGCAATTTCTCTGTGAATGGAGGGTCAGTTTCTATTTGGGTCAACAAATAA

# Drug_Target_3_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_3_General_References:
3258152	Tsukamoto A, Kimura K, Ishii Y, Takano T, Yamane K: Nucleotide sequence of the maltohexaose-producing amylase gene from an alkalophilic Bacillus sp. #707 and structural similarity to liquefying type alpha-amylases. Biochem Biophys Res Commun. 1988 Feb 29;151(1):25-31.

# Drug_Target_3_HGNC_ID:
Not Available

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
2564

# Drug_Target_3_Locus:
Not Available

# Drug_Target_3_Molecular_Weight:
59009

# Drug_Target_3_Name:
Glucan 1,4-alpha-maltohexaosidase

# Drug_Target_3_Number_of_Residues:
518

# Drug_Target_3_PDB_ID:
1WPC

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF00128	Alpha-amylase

# Drug_Target_3_Protein_Sequence:
>Glucan 1,4-alpha-maltohexaosidase precursor
MKMRTGKKGFLSILLAFLLVITSIPFTLVDVEAHHNGTNGTMMQYFEWYLPNDGNHWNRL
NSDASNLKSKGITAVWIPPAWKGASQNDVGYGAYDLYDLGEFNQKGTVRTKYGTRSQLQA
AVTSLKNNGIQVYGDVVMNHKGGADATEMVRAVEVNPNNRNQEVTGEYTIEAWTRFDFPG
RGNTHSSFKWRWYHFDGVDWDQSRRLNNRIYKFRGHGKAWDWEVDTENGNYDYLMYADID
MDHPEVVNELRNWGVWYTNTLGLDGFRIDAVKHIKYSFTRDWINHVRSATGKNMFAVAEF
WKNDLGAIENYLQKTNWNHSVFDVPLHYNLYNASKSGGNYDMRNIFNGTVVQRHPSHAVT
FVDNHDSQPEEALESFVEEWFKPLAYALTLTREQGYPSVFYGDYYGIPTHGVPAMRSKID
PILEARQKYAYGKQNDYLDHHNIIGWTREGNTAHPNSGLATIMSDGAGGSKWMFVGRNKA
GQVWSDITGNRTGTVTINADGWGNFSVNGGSVSIWVNK

# Drug_Target_3_Reaction:
Hydrolysis of 1,4-alpha-D-glucosidic linkages in amylaceous polysaccharides, to remove successive maltohexaose residues from the non-reducing chain ends

# Drug_Target_3_Signals:
1-33

# Drug_Target_3_Specific_Function:
Hydrolysis of 1,4-alpha-D-glucosidic linkages in amylaceous polysaccharides, to remove successive maltohexaose residues from the non-reducing chain ends

# Drug_Target_3_SwissProt_ID:
P19571

# Drug_Target_3_SwissProt_Name:
AMT6_BACS7

# Drug_Target_3_Synonyms:
EC 3.2.1.98
Exo-maltohexaohydrolase
G6-amylase
Glucan 1,4-alpha-maltohexaosidase precursor
Maltohexaose-producing amylase

# Drug_Target_3_Theoretical_pI:
7.07

# Drug_Target_3_Transmembrane_Regions:
None

# Drug_Target_4_Cellular_Location:
Secreted protein

# Drug_Target_4_Chromosome_Location:
Not Available

# Drug_Target_4_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_4_Essentiality:
Non-Essential

# Drug_Target_4_GenAtlas_ID:
Not Available

# Drug_Target_4_GenBank_ID_Gene:
V00101

# Drug_Target_4_GenBank_ID_Protein:
39794

# Drug_Target_4_GeneCard_ID:
Not Available

# Drug_Target_4_Gene_Name:
amyE

# Drug_Target_4_Gene_Sequence:
>1983 bp
ATGTTTGCAAAACGATTCAAAACCTCTTTACTGCCGTTATTCGCTGGATTTTTATTGCTG
TTTCATTTGGTTCTGGCAGGACCGGCGGCTGCGAGTGCTGAAACGGCGAACAAATCGAAT
GAGCTTACAGCACCGTCGATCAAAAGCGGAACCATTCTTCATGCATGGAATTGGTCGTTC
AATACGTTAAAACACAATATGAAGGATATTCATGATGCAGGATATACAGCCATTCAGACA
TCTCCGATTAACCAAGTAAAGGAAGGGAATCAAGGAGATAAAAGCATGTCGAACTGGTAC
TGGCTGTATCAGCCGACATCGTATCAAATTGGCAACCGTTACTTAGGTACTGAACAAGAA
TTTAAAGAAATGTGTGCAGCCGCTGAAGAATATGGCATAAAGGTCATTGTTGACGCGGTC
ATCAATCATACCACCAGTGATTATGCCGCGATTTCCAATGAGGTTAAGAGTATTCCAAAC
TGGACACATGGAAACACACAAATTAAAAACTGGTCTGATCGATGGGATGTCACGCAGAAT
TCATTGCTCGGGCTGTATGACTGGAATACACAAAATACACAAGTACAGTCCTATCTGAAA
CGGTTCTTAGACAGGGCATTGAATGACGGGGCAGACGGTTTTCGATTTGATGCCGCCAAA
CATATAGAGCTTCCAGATGATGGCAGTTACGGCAGTCAATTTTGGCCGAATATCACAAAT
ACATCTGCAGAGTTCCAATACGGAGAAATCCTGCAGGATAGTGCCTCCAGAGATGCTGCA
TATGCGAATTATATGGATGTGACAGCGTCTAACTATGGGCATTCCATAAGGTCCGCTTTA
AAGAATCGTAATCTGGGCGTGTCGAATATCTCCCACTATGCATCTGATGTGTCTGCGGAC
AAGCTAGTGACATGGGTAGAGTCGCATGATACGTATGCCAATGATGATGAAGAGTCGACA
TGGATGAGCGATGATGATATCCGTTTAGGCTGGGCGGTGATAGCTTCTCGTTCAGGCAGT
ACGCCTCTTTTCTTTTCCAGACCTGAGGGAGGCGGAAATGGTGTGAGGTTCCCGGGGAAA
AGCCAAATAGGCGATCGCGGGAGTGCTTTATTTGAAGATCAGGCTATCACTGCGGTCAAT
AGATTTCACAATGTGATGGCTGGACAGCCTGAGGAACTCTCGAACCCGAATGGAAACAAC
CAGATATTTATGAATCAGCGCGGCTCACATGGCGTTGTGCTGGCAAATGCAGGTTCATCC
TCTGTCTCTATCAATACGGCAACAAAATTGCCTGATGGCAGGTATGACAATAAAGCTGGA
GCGGGTTCATTTCAAGTGAACGATGGTAAACTGACAGGCACGATCAATGCCAGGTCTGTA
GCTGTGCTTTATCCTGATGATATTGCAAAAGCGCCTCATGTTTTCCTTGAGAATTACAAA
ACAGGTGTAACACATTCTTTCAATGATCAACTGACGATTACCTTGCGTGCAGATGCGAAT
ACAACAAAAGCCGTTTATCAAATCAATAATGGACCAGACGACAGGCGTTTAAGGATGGAG
ATCAATTCACAATCGGAAAAGGAGATCCAATTTGGCAAAACATACACCATCATGTTAAAA
GGAACGAACAGTGATGGTGTAACGAGGACCGAGAAATACAGTTTTGTTAAAAGAGATCCA
GCGTCGGCCAAAACCATCGGCTATCAAAATCCGAATCATTGGAGCCAGGTAAATGCTTAT
ATCTATAAACATGATGGGAGCCGAGTAATTGAATTGACCGGATCTTGGCCTGGAAAACCA
ATGACTAAAAATGCAGACGGAATTTACACGCTGACGCTGCCTGCGGACACGGATACAACC
AACGCAAAAGTGATTTTTAATAATGGCAGCGCCCAAGTGCCCGGTCAGAATCAGCCTGGC
TTTGATTACGTGCTAAATGGTTTATATAATGACTCGGGCTTAAGCGGTTCTCTTCCCCAT
TGA

# Drug_Target_4_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_4_General_References:
112102	Mantsala P, Zalkin H: Membrane-bound and soluble extracellular alpha-amylase from Bacillus subtilis. J Biol Chem. 1979 Sep 10;254(17):8540-7.
6099357	Yamane K, Hirata Y, Furusato T, Yamazaki H, Nakayama A: Changes in the properties and molecular weights of Bacillus subtilis M-type and N-type alpha-amylases resulting from a spontaneous deletion. J Biochem (Tokyo). 1984 Dec;96(6):1849-58.
6186986	Yang M, Galizzi A, Henner D: Nucleotide sequence of the amylase gene from Bacillus subtilis. Nucleic Acids Res. 1983 Jan 25;11(2):237-49.
6189486	Ohmura K, Yamazaki H, Takeichi Y, Nakayama A, Otozai K, Yamane K, Yamasaki M, Tamura G: Nucleotide sequence of the promoter and NH2-terminal signal peptide region of Bacillus subtilis alpha-amylase gene cloned in pUB110. Biochem Biophys Res Commun. 1983 Apr 29;112(2):678-83.
6413492	Yamazaki H, Ohmura K, Nakayama A, Takeichi Y, Otozai K, Yamasaki M, Tamura G, Yamane K: Alpha-amylase genes (amyR2 and amyE+) from an alpha-amylase-hyperproducing Bacillus subtilis strain: molecular cloning and nucleotide sequences. J Bacteriol. 1983 Oct;156(1):327-37.
8969502	Yamane K, Kumano M, Kurita K: The 25 degrees-36 degrees region of the Bacillus subtilis chromosome: determination of the sequence of a 146 kb segment and identification of 113 genes. Microbiology. 1996 Nov;142 ( Pt 11):3047-56.
9384377	Kunst F, Ogasawara N, Moszer I, Albertini AM, Alloni G, Azevedo V, Bertero MG, Bessieres P, Bolotin A, Borchert S, Borriss R, Boursier L, Brans A, Braun M, Brignell SC, Bron S, Brouillet S, Bruschi CV, Caldwell B, Capuano V, Carter NM, Choi SK, Codani JJ, Connerton IF, Danchin A, et al.: The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature. 1997 Nov 20;390(6657):249-56.
9514750	Fujimoto Z, Takase K, Doui N, Momma M, Matsumoto T, Mizuno H: Crystal structure of a catalytic-site mutant alpha-amylase from Bacillus subtilis complexed with maltopentaose. J Mol Biol. 1998 Mar 27;277(2):393-407.

# Drug_Target_4_HGNC_ID:
Not Available

# Drug_Target_4_HPRD_ID:
Not Available

# Drug_Target_4_ID:
2531

# Drug_Target_4_Locus:
Not Available

# Drug_Target_4_Molecular_Weight:
72800

# Drug_Target_4_Name:
Alpha-amylase

# Drug_Target_4_Number_of_Residues:
660

# Drug_Target_4_PDB_ID:
1BAG

# Drug_Target_4_Pathway:
Not Available

# Drug_Target_4_Pfam_Domain_Function:
PF00128	Alpha-amylase
PF02806	Alpha-amylase_C

# Drug_Target_4_Protein_Sequence:
>Alpha-amylase precursor
MFAKRFKTSLLPLFAGFLLLFHLVLAGPAAASAETANKSNELTAPSIKSGTILHAWNWSF
NTLKHNMKDIHDAGYTAIQTSPINQVKEGNQGDKSMSNWYWLYQPTSYQIGNRYLGTEQE
FKEMCAAAEEYGIKVIVDAVINHTTSDYAAISNEVKSIPNWTHGNTQIKNWSDRWDVTQN
SLLGLYDWNTQNTQVQSYLKRFLDRALNDGADGFRFDAAKHIELPDDGSYGSQFWPNITN
TSAEFQYGEILQDSASRDAAYANYMDVTASNYGHSIRSALKNRNLGVSNISHYASDVSAD
KLVTWVESHDTYANDDEESTWMSDDDIRLGWAVIASRSGSTPLFFSRPEGGGNGVRFPGK
SQIGDRGSALFEDQAITAVNRFHNVMAGQPEELSNPNGNNQIFMNQRGSHGVVLANAGSS
SVSINTATKLPDGRYDNKAGAGSFQVNDGKLTGTINARSVAVLYPDDIAKAPHVFLENYK
TGVTHSFNDQLTITLRADANTTKAVYQINNGPDDRRLRMEINSQSEKEIQFGKTYTIMLK
GTNSDGVTRTEKYSFVKRDPASAKTIGYQNPNHWSQVNAYIYKHDGSRVIELTGSWPGKP
MTKNADGIYTLTLPADTDTTNAKVIFNNGSAQVPGQNQPGFDYVLNGLYNDSGLSGSLPH

# Drug_Target_4_Reaction:
Endohydrolysis of 1,4-alpha-D-glucosidic linkages in polysaccharides containing three or more 1,4-alpha-linked D-glucose units ALL_REAC (other) R02108 R06209(G)

# Drug_Target_4_Signals:
1-27

# Drug_Target_4_Specific_Function:
Endohydrolysis of 1,4-alpha-D-glucosidic linkages in oligosaccharides and polysaccharides

# Drug_Target_4_SwissProt_ID:
P00691

# Drug_Target_4_SwissProt_Name:
AMY_BACSU

# Drug_Target_4_Synonyms:
1,4-alpha-D-glucan glucanohydrolase
Alpha-amylase precursor
EC 3.2.1.1

# Drug_Target_4_Theoretical_pI:
6.27

# Drug_Target_4_Transmembrane_Regions:
None

# Drug_Target_5_Cellular_Location:
Secreted protein

# Drug_Target_5_Chromosome_Location:
Not Available

# Drug_Target_5_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_5_Essentiality:
Non-Essential

# Drug_Target_5_GenAtlas_ID:
Not Available

# Drug_Target_5_GenBank_ID_Gene:
D13177

# Drug_Target_5_GenBank_ID_Protein:
1648826

# Drug_Target_5_GeneCard_ID:
Not Available

# Drug_Target_5_Gene_Name:
tvaI

# Drug_Target_5_Gene_Sequence:
>2001 bp
ATGATCAAATTATTAAAGCCGATGTCTTTGTCCATCCTCCTTGTCTTCATTCTCTCATTT
TCTTTTCCATTTCCCACGGCAAAGGCGGCCGCCAATGACAACAATGTGGAGTGGAATGGA
TTGTTTCATGATCAAGGCCCGCTTTTTGACAACGCGCCGGAGCCCACTTCAACCCAGAGT
GTCACGCTTAAACTGCGAACCTTCAAAGGAGATATTACCAGCGCCAATATCAAGTATTGG
GATACTGCCGACAATGCCTTTCACTGGGTGCCCATGGTTTGGGATTCCAATGACCCGACA
GGCACGTTTGATTACTGGAAAGGGACGATCCCGGCAAGCCCATCGATCAAGTATTACCGT
TTCCAAATTAACGATGGCACAAGCACGGCCTGGTACAACGGCAATGGCCCTTCTTCCACC
GAACCGAATGCCGATGATTTTTATATTATTCCCAATTTCAAAACGCCGGACTGGCTGAAA
AACGGCGTAATGTACCAGATCTTTCCGGATCGTTTCTACAATGGCGATTCTTCAAATGAT
GTCCAGACAGGCTCCTATACCTATAACGGCACCCCAACGGAGAAAAAAGCATGGGGCAGC
AGCGTTTACGCTGATCCGGGGTACGACAATAGTTTGGTCTTTTTTGGCGGAGACCTGGCG
GGAATCGATCAAAAACTGGGCTATATCAAAAAGACTCTCGGCGCGAACATCCTCTATCTG
AATCCCATCTTCAAGGCGCCAACCAACCACAAATACGACACCCAGGACTACATGGCGGTT
GATCCCGCGTTTGGCGACAATTCCACCTTGCAAACGCTGATCAACGACATACACAGCACC
GCGAACGGCCCTAAAGGGTACCTTATTTTGGACGGGGTGTTCAACCACACGGGAGACAGC
CATCCGTGGTTTGACAAATACAATAATTTTTCGTCTCAGGGAGCATACGAGTCACAATCC
AGCCCATGGTACAACTACTATACTTTCTACACATGGCCCGATTCATACGCTTCTTTTCTC
GGATTCAACAGTTTGCCCAAACTAAACTACGGCAACAGCGGTTCAGCCGTACGGGGCGTA
ATCTACAACAACAGCAATTCGGTGGCTAAAACCTATTTAAACCCGCCTTATTCTGTCGAT
GGTTGGCGGCTCGATGCAGCACAATATGTTGACGCAAATGGCAACAATGGAAGTGACGTG
ACCAACCACCAGATTTGGAGCGAATTTCGGAATGCCGTCAAGGGAGTGAATTCAAACGCC
GCAATCATCGGGGAGTATTGGGGCAACGCCAATCCATGGACGGCCCAGGGAAACCAGTGG
GACGCAGCCACCAACTTTGATGGCTTCACCCAGCCTGTTTCTGAATGGATTACCGGCAAA
GACTACCAAAACAATTCGGCTTCGATCAGCACCACACAGTTTGACAGTTGGCTTAGGGGG
ACACGGGCCAACTACCCTACCAATGTCCAACAGTCCATGATGAACTTCCTTTCCAATCAT
GACATCACCCGCTTTGCCACACGTTCCGGCGGAGATCTTTGGAAAACCTACTTGGCCCTG
ATCTTTCAGATGACTTATGTGGGCACTCCGACCATTTACTATGGGGACGAATACGGCATG
CAGGGAGGCGCGGACCCCGACAACCGCCGGTCCTTTGATTGGTCACAAGCCACTCCCTCC
AATAGCGCGGTGGCCCTGACCCAAAAGCTGATCACCATTCGCAACCAATACCCTGCTTTA
AGAACCGGTTCCTTTATGACATTAATCACGGACGACACCAACAAAATTTATTCTTATGGG
CGTTTTGACAACGTCAACCGAATCGCCGTCGTGCTAAACAATGACTCCGTCAGCCATACG
GTCAACGTGCCGGTTTGGCAACTCAGCATGCCAAATGGCAGCACTGTCACGGACAAAATT
ACCGGCCATAGTTACACCGTACAAAACGGCATGGTTACCGTTGCCGTTGACGGGCACTAC
GGCGCTGTCTTGGCACAATAA

# Drug_Target_5_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_5_General_References:
12051850	Kamitori S, Abe A, Ohtaki A, Kaji A, Tonozuka T, Sakano Y: Crystal structures and structural comparison of Thermoactinomyces vulgaris R-47 alpha-amylase 1 (TVAI) at 1.6 A resolution and alpha-amylase 2 (TVAII) at 2.3 A resolution. J Mol Biol. 2002 Apr 26;318(2):443-53.
7548164	Tonozuka T, Mogi S, Shimura Y, Ibuka A, Sakai H, Matsuzawa H, Sakano Y, Ohta T: Comparison of primary structures and substrate specificities of two pullulan-hydrolyzing alpha-amylases, TVA I and TVA II, from Thermoactinomyces vulgaris R-47. Biochim Biophys Acta. 1995 Sep 27;1252(1):35-42.

# Drug_Target_5_HGNC_ID:
Not Available

# Drug_Target_5_HPRD_ID:
Not Available

# Drug_Target_5_ID:
2541

# Drug_Target_5_Locus:
Not Available

# Drug_Target_5_Molecular_Weight:
74296

# Drug_Target_5_Name:
Neopullulanase 1

# Drug_Target_5_Number_of_Residues:
666

# Drug_Target_5_PDB_ID:
1UH3

# Drug_Target_5_Pathway:
Not Available

# Drug_Target_5_Pfam_Domain_Function:
PF00128	Alpha-amylase
PF02903	Alpha-amylase_N

# Drug_Target_5_Protein_Sequence:
>Neopullulanase 1 precursor
MIKLLKPMSLSILLVFILSFSFPFPTAKAAANDNNVEWNGLFHDQGPLFDNAPEPTSTQS
VTLKLRTFKGDITSANIKYWDTADNAFHWVPMVWDSNDPTGTFDYWKGTIPASPSIKYYR
FQINDGTSTAWYNGNGPSSTEPNADDFYIIPNFKTPDWLKNGVMYQIFPDRFYNGDSSND
VQTGSYTYNGTPTEKKAWGSSVYADPGYDNSLVFFGGDLAGIDQKLGYIKKTLGANILYL
NPIFKAPTNHKYDTQDYMAVDPAFGDNSTLQTLINDIHSTANGPKGYLILDGVFNHTGDS
HPWFDKYNNFSSQGAYESQSSPWYNYYTFYTWPDSYASFLGFNSLPKLNYGNSGSAVRGV
IYNNSNSVAKTYLNPPYSVDGWRLDAAQYVDANGNNGSDVTNHQIWSEFRNAVKGVNSNA
AIIGEYWGNANPWTAQGNQWDAATNFDGFTQPVSEWITGKDYQNNSASISTTQFDSWLRG
TRANYPTNVQQSMMNFLSNHDITRFATRSGGDLWKTYLALIFQMTYVGTPTIYYGDEYGM
QGGADPDNRRSFDWSQATPSNSAVALTQKLITIRNQYPALRTGSFMTLITDDTNKIYSYG
RFDNVNRIAVVLNNDSVSHTVNVPVWQLSMPNGSTVTDKITGHSYTVQNGMVTVAVDGHY
GAVLAQ

# Drug_Target_5_Reaction:
Hydrolysis of pullulan to panose (6-alpha-D-glucosylmaltose)

# Drug_Target_5_Signals:
1-29

# Drug_Target_5_Specific_Function:
Endohydrolysis of 1,4-alpha-glucosidic linkages in pullulan to form panose. Also hydrolyzes cyclodextrins

# Drug_Target_5_SwissProt_ID:
Q60053

# Drug_Target_5_SwissProt_Name:
NEPU1_THEVU

# Drug_Target_5_Synonyms:
Alpha-amylase I
EC 3.2.1.135
Neopullulanase 1 precursor
TVA I

# Drug_Target_5_Theoretical_pI:
5.03

# Drug_Target_5_Transmembrane_Regions:
None

#END_DRUGCARD DB02120
